Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kyntra Bio
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
have a diagnosis of idiopathic pulmonary fibrosis (IPF) by clinical features and surgical lung biopsy or according to the American Thoracic Society criteria
You may not be if
have a history of significant exposure to organic or inorganic dust or drugs known to cause pulmonary fibrosis
have interstitial lung disease other than IPF
have pulmonary fibrosis associated with connective tissue disease
have other forms of idiopathic interstitial pneumonia, such as desquamative interstitial pneumonia, acute interstitial pneumonia, nonspecific interstitial pneumonia, or cryptogenic organizing pneumonia
have end-stage IPF (total lung capacity of less than 45% of predicted value)
are listed for lung transplantation at the time of study enrollment
have significant heart problems
are pregnant or lactating (if female)
Clareo Health | Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis
